0001209191-17-045842.txt : 20170720 0001209191-17-045842.hdr.sgml : 20170720 20170720170840 ACCESSION NUMBER: 0001209191-17-045842 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170718 FILED AS OF DATE: 20170720 DATE AS OF CHANGE: 20170720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gergel Ivan P. CENTRAL INDEX KEY: 0001328288 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 17974819 MAIL ADDRESS: STREET 1: C/O NEKTAR THERAPEUTICS STREET 2: 455 MISSION BAY BLVD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER NAME: FORMER CONFORMED NAME: Gergel Ivan DATE OF NAME CHANGE: 20050525 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4154825300 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-18 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001328288 Gergel Ivan P. C/O NEKTAR THERAPEUTICS 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 0 1 0 0 SVP & Chief Medical Officer Common Stock 2017-07-18 4 M 0 54920 11.04 A 98492 D Common Stock 2017-07-18 4 S 0 54920 21.10 D 43572 D Stock Option 11.04 2017-07-18 4 M 0 54920 0.00 D 2015-05-19 2022-05-18 Common Stock 54920 413752 D This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This transaction was executed in multiple trades at prices ranging from $21.04 to $21.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Mark A. Wilson, Attorney-in-Fact 2017-07-20